An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity

Chihiro Motozono(Kumamoto University), Kei Sato(National Institute of Infectious Diseases)
bioRxiv (Cold Spring Harbor Laboratory)
April 5, 2021
10.1101/2021.04.02.438288
Cited by 74

Related Papers

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
|Nature|2022|748
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
|Cell Reports|2020|438
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75
|bioRxiv (Cold Spring Harbor Laboratory)|2022|44
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
|bioRxiv (Cold Spring Harbor Laboratory)|2023|24
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant
|bioRxiv (Cold Spring Harbor Laboratory)|2023|20